| Old Articles: <Older 5631-5640 Newer> |
|---|
 |
The Motley Fool
May 18, 2009
Brian Orelli |
Onyx Cries, "Et Tu, Brute?" The company is suing for the rights to a drug that marketing partner Bayer is developing.   |
The Motley Fool
May 18, 2009
Brian Orelli |
Free Drugs! Pfizer's giving over 70 drugs away -- to people who have lost their jobs and health insurance recently and can show financial hardship. |
Chemistry World
May 15, 2009
Katrina Megget |
Tripping over red tape The UK may be moving a step closer to allowing the use of a cannabis-based drug to treat the symptoms of multiple sclerosis |
Chemistry World
May 14, 2009
Rebecca Trager |
Bloodshed for blood substitute makers The synthetic blood business has taken a hit as regulators pan products and two major players are brought to the brink of collapse. |
Pharmaceutical Executive
May 1, 2009 |
Why All the Bad Buzz? European docs have always been down on pharma - but now the US is catching on. Perhaps pharma has oversold the "service model." |
Pharmaceutical Executive
May 1, 2009 |
Bank on IT Tough economic times call for a bold approach to evolving information technology solutions. |
Pharmaceutical Executive
May 1, 2009 |
Ad(Ventures) in Pharmaland Despite the downside in ad spend, an upside remains in the digital space that's wide open for exploration. |
Pharmaceutical Executive
May 1, 2009 |
The Fate of Mannkind Al Mann has sunk almost $1 billion of his own money into a new insulin delivery system. Will FDA be persuaded? |
Pharmaceutical Executive
May 1, 2009 |
The Shakeout When it comes to licensing in this market, there are winners and losers. Learn the new rules of the game. |
Pharmaceutical Executive
May 1, 2009
Michael R. Perry |
Your Most Precious Asset Eleven Ways to attract and retain top advertising talent. |
| <Older 5631-5640 Newer> Return to current articles. |
